Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

WH Geerts, GF Pineo, JA Heit, D Bergqvist, MR Lassen… - Chest, 2004 - Elsevier
This article discusses the prevention of venous thromboembolism (VTE) and is part of the
Seventh American College of Chest Physicians Conference on Antithrombotic and …

'Pseudopalisading'necrosis in glioblastoma: a familiar morphologic feature that links vascular pathology, hypoxia, and angiogenesis

Y Rong, DL Durden, EG Van Meir… - … of Neuropathology & …, 2006 - academic.oup.com
Glioblastoma (GBM) is a highly malignant, rapidly progressive astrocytoma that is
distinguished pathologically from lower grade tumors by necrosis and microvascular …

Prevention of venous thromboembolism: American College of Chest Physicians evidence-based clinical practice guidelines

WH Geerts, D Bergqvist, GF Pineo, JA Heit… - Chest, 2008 - Elsevier
This article discusses the prevention of venous thromboembolism (VTE) and is part of the
Antithrombotic and Thrombolytic Therapy: American College of Chest Physicians Evidence …

Pseudopalisades in glioblastoma are hypoxic, express extracellular matrix proteases, and are formed by an actively migrating cell population

DJ Brat, AA Castellano-Sanchez, SB Hunter, M Pecot… - Cancer research, 2004 - AACR
Necrosis and vascular proliferation are the pathologic features that distinguish the most
malignant infiltrative astrocytoma, glioblastoma (GBM), from those of lower grades. In GBM …

[HTML][HTML] Vaso-occlusive and prothrombotic mechanisms associated with tumor hypoxia, necrosis, and accelerated growth in glioblastoma

DJ Brat, EG Van Meir - Laboratory investigation, 2004 - Elsevier
Glioblastoma (GBM) has explosive biologic properties with rapid clinical progression
leading to death. Its distinguishing pathologic features, necrosis with surrounding …

[PDF][PDF] Prevention of venous thromboembolism

WH Geerts, D Bergqvist, GF Pineo, JA Heit… - Chest, 2008 - nnt.pharm.su.ac.th
This article discusses the prevention of venous thromboembolism (VTE) and is part of the
Antithrombotic and Thrombolytic Therapy: American College of Chest Physicians Evidence …

Current management of glioblastoma multiforme

SA Grossman, JF Batara - Seminars in oncology, 2004 - Elsevier
Glioblastoma multiforme is the most common primary brain tumor in adults. Despite major
research efforts and progress in neuroimaging, neurosurgery, and radiation and medical …

Therapeutic advances in the treatment of glioblastoma: rationale and potential role of targeted agents

DA Reardon, PY Wen - The oncologist, 2006 - academic.oup.com
Learning Objectives After completing this course, the reader will be able to: Describe the
genetic alterations frequently observed in GBM tumors as well as the cell signal transduction …

PTEN and hypoxia regulate tissue factor expression and plasma coagulation by glioblastoma

Y Rong, DE Post, RO Pieper, DL Durden, EG Van Meir… - Cancer research, 2005 - AACR
We have previously proposed that intravascular thrombosis and subsequent vasoocclusion
contribute to the development of pseudopalisading necrosis, a pathologic hallmark that …

Medical management of patients with brain tumors

PY Wen, D Schiff, S Kesari, J Drappatz… - Journal of neuro …, 2006 - Springer
The most common medical problems in brain tumor patients include the management of
seizures, peritumoral edema, medication side effects, venous thromboembolism (VTE) …